» Articles » PMID: 25385786

Volatile Anesthetics Inhibit Sodium Channels Without Altering Bulk Lipid Bilayer Properties

Overview
Journal J Gen Physiol
Specialty Physiology
Date 2014 Nov 12
PMID 25385786
Citations 16
Authors
Affiliations
Soon will be listed here.
Abstract

Although general anesthetics are clinically important and widely used, their molecular mechanisms of action remain poorly understood. Volatile anesthetics such as isoflurane (ISO) are thought to alter neuronal function by depressing excitatory and facilitating inhibitory neurotransmission through direct interactions with specific protein targets, including voltage-gated sodium channels (Na(v)). Many anesthetics alter lipid bilayer properties, suggesting that ion channel function might also be altered indirectly through effects on the lipid bilayer. We compared the effects of ISO and of a series of fluorobenzene (FB) model volatile anesthetics on Na(v) function and lipid bilayer properties. We examined the effects of these agents on Na(v) in neuronal cells using whole-cell electrophysiology, and on lipid bilayer properties using a gramicidin-based fluorescence assay, which is a functional assay for detecting changes in lipid bilayer properties sensed by a bilayer-spanning ion channel. At clinically relevant concentrations (defined by the minimum alveolar concentration), both the FBs and ISO produced prepulse-dependent inhibition of Na(v) and shifted the voltage dependence of inactivation toward more hyperpolarized potentials without affecting lipid bilayer properties, as sensed by gramicidin channels. Only at supra-anesthetic (toxic) concentrations did ISO alter lipid bilayer properties. These results suggest that clinically relevant concentrations of volatile anesthetics alter Na(v) function through direct interactions with the channel protein with little, if any, contribution from changes in bulk lipid bilayer properties. Our findings further suggest that changes in lipid bilayer properties are not involved in clinical anesthesia.

Citing Articles

Functionally important binding site for a volatile anesthetic in a voltage-gated sodium channel identified by X-ray crystallography.

Hollingworth D, Herold K, Kelly G, Mykhaylyk V, Xiang J, Zhang D bioRxiv. 2024; .

PMID: 39574657 PMC: 11580951. DOI: 10.1101/2024.11.04.621342.


Nonspecific membrane bilayer perturbations by ivermectin underlie SARS-CoV-2 activity.

Eastman R, Rusinova R, Herold K, Huang X, Dranchak P, Voss T bioRxiv. 2023; .

PMID: 37961094 PMC: 10634736. DOI: 10.1101/2023.10.23.563088.


Screening for bilayer-active and likely cytotoxic molecules reveals bilayer-mediated regulation of cell function.

Peyear T, Andersen O J Gen Physiol. 2023; 155(4).

PMID: 36763053 PMC: 9948646. DOI: 10.1085/jgp.202213247.


Assessing the Perturbing Effects of Drugs on Lipid Bilayers Using Gramicidin Channel-Based and Assays.

Sun D, Peyear T, Bennett W, Holcomb M, He S, Zhu F J Med Chem. 2020; 63(20):11809-11818.

PMID: 32945672 PMC: 7586341. DOI: 10.1021/acs.jmedchem.0c00958.


Molecular Mechanism for Gramicidin Dimerization and Dissociation in Bilayers of Different Thickness.

Sun D, Peyear T, Bennett W, Andersen O, Lightstone F, Ingolfsson H Biophys J. 2019; 117(10):1831-1844.

PMID: 31676135 PMC: 7018991. DOI: 10.1016/j.bpj.2019.09.044.


References
1.
Zeller A, Jurd R, Lambert S, Arras M, Drexler B, Grashoff C . Inhibitory ligand-gated ion channels as substrates for general anesthetic actions. Handb Exp Pharmacol. 2008; (182):31-51. DOI: 10.1007/978-3-540-74806-9_2. View

2.
Lee A . How lipids affect the activities of integral membrane proteins. Biochim Biophys Acta. 2004; 1666(1-2):62-87. DOI: 10.1016/j.bbamem.2004.05.012. View

3.
Lundbaek J, Andersen O . Lysophospholipids modulate channel function by altering the mechanical properties of lipid bilayers. J Gen Physiol. 1994; 104(4):645-73. PMC: 2229230. DOI: 10.1085/jgp.104.4.645. View

4.
Sogaard R, Werge T, Bertelsen C, Lundbye C, Madsen K, Nielsen C . GABA(A) receptor function is regulated by lipid bilayer elasticity. Biochemistry. 2006; 45(43):13118-29. DOI: 10.1021/bi060734+. View

5.
Ingolfsson H, Andersen O . Screening for small molecules' bilayer-modifying potential using a gramicidin-based fluorescence assay. Assay Drug Dev Technol. 2010; 8(4):427-36. PMC: 2929145. DOI: 10.1089/adt.2009.0250. View